Taisho Expands in Asia by Acquiring Malaysia's
Total Page:16
File Type:pdf, Size:1020Kb
OTC15-04-11p1&24FIN.qxd 14/4/11 12:47 Page 1 15 April 2011 COMPANY NEWS 3 Taisho expands in Asia by J&J isolates McNeil in 3 Consumer shake-up Boehringer looks to 4 switches for growth acquiring Malaysia’s Hoe Private-equity group KKR 5 to gain Pfizer’s Capsugel Adcock is set to acquire 6 aisho Pharmaceutical is set to grow its Noting that Hoe was the “leading local phar- NutriLida in South Africa Tpresence outside of Japan by acquiring maceutical company in Malaysia”, Taisho said Stadais ready to make 7 Malaysia’s Hoe Pharmaceuticals for approx- its products were available in more than 40 big acquisitions imately MYR370 million (C85.5 million). countries, the majority of which were in Asia. Oxford Nutrascience sees 8 Japan’s leading OTC company said the deal Acquiring Hoe is in line with Taisho’s strat- growth in pharmaceuticals enabled it to enter the Malaysian pharmaceu- egyof expanding its Asian operations, which US Supreme Court rules 9 tical market “in earnest”, and also to grow its saw the company buy Bristol-Myers Squibb’s against Matrixx business across Asia by using Hoe’s distribu- OTC assets in the Asia-Pacific region, exclud- tion channels to sell its existing products. ing China and Japan, in 2009 (OTC bulletin, GENERAL NEWS 10 Taisho said the transaction was expected to 30 September 2009, page 1). The US$310 mil- close in August of this year. lion (C217 million) deal included the rights to EMA consults on 10 OTC pack design Under the terms of the deal, Taisho is paying the Tempra antipyretic analgesic, Counterpain almost five-times Hoe’s annual sales of MYR76 topical analgesic, Theragran-M and Engran Diclofenac and ibuprofen 11 on draft list of pollutants million, which are generated by a portfolio of multivitamin products, Ceetrus paediatric drops consumer and medical dermatology products. and the Keri brand, as well as Bristol-Myers Australia’s TGA settles 12 Pan case for A$67.5m Hoe’s portfolio of consumer dermatology Squibb’s Indonesian subsidiary. products includes the Baby Shield brand, as Prior to the Bristol-Myers Squibb deal, the German pharmacy customers 13 have specific product in mind well as the Neucare T3, Neucare Men, and T3 bulk of Taisho’s overseas operation was built FDA rule on supplement GMP 14 Acne face-care lines. The company also offers around its Lipovitan health drink brand, which is not arbitrary and capricious the Daily Repair and Ellgy hand- and body-care the company sells through local subsidiaries in EFSA’s fourth batch 15 brands, Ellgy cracked-heel repair products, Hair- China, Hong Kong, Indonesia, Malaysia, the sparks call for change monius haircare line, and Orregel teething gel. Philippines, Taiwan, Thailand and Vietnam. MARKETING NEWS 16 Seven Seas shakes up 16 Germany may ban JointCare range in UK US FDA warns PL gains exclusive rights 17 OTC paracetamol to store-brand Zegerid OTC on benzocaine FEATURES 20 everse-switching all paracetamol medi- onsumers in the US have been warned by Rcines to prescription-only status in Ger- Steady growth for most in 2010 20 Cthe Food and Drug Administration (FDA) manyis on the agenda for discussion when the A round up of the annual results that applying OTCbenzocaine gels and liquids country’s Expert Committee for Prescription to the gums or mouth is associated with a rare, next meets on 5 July this year. REGULARS but potentially-fatal, adverse effect. Similar reverse-switches for dextromethor- Events – Our regular listing 19 The regulatory agency said it was particu- phan and topical ketoprofen are also on the People – Latest moves 22 larly concerned about the use of OTC benzo- agenda for the meeting. caine gels and liquids in children for relief of A spokesperson for Germany’s medicines Becht to leave Reckitt teething pain, because of the serious outcomes, manufacturers’ association, the BAH, told OTC Bart Becht will retire as chief executive officer including death, that may be associated with bulletin that he was not aware “of any new of Reckitt Benckiser on 1 September 2011. Ra- methemoglobinemia. Consumers might have evidence” that would support removing parac- kesh Kapoor,the company’s executive vice-pres- difficulty recognising the signs and symptoms etamol medicines from non-prescription use. ident of category development, has been named when using such products at home, added the Earlier this year,the BAH spokesperson chief executive officer designate. Reckitt Ben- ckiser noted that Becht would act as a part-time agency, noting the symptoms might not always pointed out, the Pharmacovigilance Working adviser to Kapoor until September 2012. be evident or attributed to the condition. Party within the European Medicines Agency ■ Continued on page 22 ■ Continued on page 22 OTC15-04-11p2-3FIN.qxd 14/4/11 12:53 Page 3 COMPANY NEWS OTC Business Strategy J&J isolates McNeil in Consumer shake-up ohnson & Johnson is to isolate its McNeil lion (C768 million) in 2010, after McNeil issu- has also made a number of appointments, all of JConsumer Healthcare business in the US, as ed a series of products recalls (OTC bulletin, whom will report to Jesse Wu,worldwide chair- it attempts to repair the damage caused by a 11 February 2011, page 4). These included a man of the Consumer division. series of products recalls and the closure of its recall of over 40 OTC medicines for infants Pat Mutchler has been named as company Fort Washington manufacturing facility. and children, which prompted a US government group chairman of US OTC, McNeil Nutrition- McNeil Consumer Healthcare in the US investigation and the closure of the company’s als and Wellness & Prevention, as well as the would operate from April as a separate business Fort Washington facility (OTC bulletin,14 Johnson & Johnson/Merck Consumer Pharma- under the Consumer umbrella, Johnson & John- May 2010, page 1). ceuticals joint venture. son said. This would enable the firm to give the Mutchler will be supported by Denice Tor- “focused attention to quality and compliance” Wider restructuring of Consumer division res, who has been appointed president of Mc- that was needed to complete the “critical task” The latest move forms part of wider changes Neil Consumer Healthcare. Torres will take up of restoring McNeil’s reputation. to the firm’s global Consumer division. the role on 25 April 2011. US sales at Johnson & Johnson’s OTC& Under the new structure, the Consumer div- Torres joined Johnson & Johnson in 2005 Nutritionals business dropped by US$1.09 bil- ision will consist of a global franchise organ- as vice-president, marketing, at the Ortho-Mc- isation composed of four consumer categories Neil Neurologics business. In 2007, she was – Skin Care for Baby and Adult; OTC; Oral named vice-president of US sales and market- OTC bulletin Care and Topical Health; and Women’s and ing at Ethicon and was promoted to her current Intimate Health – and four regional business position of president, central nervous system 15 April 2011 Number 360 units that will market the various consumer business at Ortho-McNeil-Janssen Pharmaceut- product lines. icals in 2009. Editor & Publisher: Deborah Wilkes Three of the four regional units – Asia-Pac- Prior to joining Johnson & Johnson, Torres Associate Editors: Aidan Fry ific, Europe/Middle East/Africa and Latin Am- spent 15 years at Eli Lilly and Company. Mike Rice erica – will market all the consumer product Grace Castano has been made company Business Editor: Matt Stewart lines. The North America unit will market all group chairman for the Asia-Pacific region, Assistant Editors: Jenna Lawrence product lines except OTC medicines in the US. while Jose Justino has taken the same role in David Wallace Johnson & Johnson said the new structure the Europe/Middle East/Africa region. Advertising Controller: Debi Minal would enable the company to react more rapid- The North America unit’s company group ly to changing market conditions and execute chairman will be Roberto Marques, and Susan Marketing Manager: Val Davis region-wide initiatives more efficiently. Further- Rivetti has been named international vice-pres- Editorial, Subscription and Advertising more, it would accelerate growth in emerging ident for Latin America. enquiries should be addressed to: OTC bulletin, OTC Publications Ltd, 54 Creynolds Lane, Solihull, markets, added the company. Pericles Stamatiades will take charge of West Midlands B90 4ER, UK. In light of the changes, Johnson & Johnson Consumer’s global franchise organisation. Tel: +44 1564 777550. Fax: +44 1564 777524. OTC E-mail: [email protected]. Subscriptions Annual subscriptions to OTC bulletin in Europe are £625.00 for Mergers & Acquisitions single copies and £355.00 for additional copies to the same ad- dress, including delivery. Subscriptions to addresses outside Eur- ope are subject to an additional charge of £30.00 to cover postage. Lloydspharmacy takes over DrThom Subscription enquiries in Korea should be directed to Pharma Koreana Ltd, 14th Floor,KTB Network Building, 826-14 Yeoksam- loydspharmacy has expanded its online the Lloydspharmacy partnership had begun, the dong, Kangnam-gu, Seoul 135-080, Korea (Tel: +82 2 554 9591; L presence in the UK by acquiring for an un- company said, noting that DrThom offered con- Fax: +82 2 563 8289; E-mail: [email protected]). Advertising disclosed sum the 67% share in online doctor sultations on premature ejaculation, erectile dys- Advertising rates and data are available on request from the ad- service DrThom it did not already own. function, contraception and sexually-transmit- dress above or at www.otc-bulletin.com. About OTC bulletin The Celesio-owned pharmacy chain acquired ted infections, as well as a travel clinic and ser- OTC bulletin is published 20 times a year by OTC Publications in August 2009 a 33% stake in DrThom, which vices for hair loss and quitting smoking .